【Genmont】February 2026 Monthly Revenue NT$0.16 Billion (YoY -35.5%)
Genmont Biotechnology announced its February 2026 monthly revenue was NT$0.16 billion, a year-on-year decrease of 35.5%. This biomedical company specializes in probiotic products, and its monthly revenue data reflects the current market sales conditions and challenges it faces.
📋 Article Processing Timeline
- 📰 Published: February 1, 2026 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (1559h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:19 (16h 19m after Collected)
Company Code: 3164
Company Name: Genmont
Industry: Biomedical Industry
Data Month/Year: 2026-02
Current Month Revenue: 16,413 Thousand NTD (NT$0.16 Billion)
Year-on-Year Change: -35.5%
Company Name: Genmont
Industry: Biomedical Industry
Data Month/Year: 2026-02
Current Month Revenue: 16,413 Thousand NTD (NT$0.16 Billion)
Year-on-Year Change: -35.5%